SOLIQUA 100/33: payments to doctors
Payments that named SOLIQUA 100/33 as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $10.5M
- Providers
- 37,968
- Transactions
- 182,436
- Average per transaction
- $58
The per-transaction average — $58 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 37,968 providers the average total is $278, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Sanofi-aventis U.S. LLC | $10,474,032 | 99.3% |
| Sanofi US Services Inc. | $40,437 | 0.4% |
| Sanofi | $28,281 | 0.3% |
| Sanofi Pasteur Inc. | $121 | 0.0% |